A synthetic TLR4 antagonist has anti-inflammatory effects in two murine models of inflammatory bowel disease.
Fort MM, Mozaffarian A, Stöver AG, Correia Jda S, Johnson DA, Crane RT, Ulevitch RJ, Persing DH, Bielefeldt-Ohmann H, Probst P, Jeffery E, Fling SP, Hershberg RM.
Fort MM, et al. Among authors: crane rt.
J Immunol. 2005 May 15;174(10):6416-23. doi: 10.4049/jimmunol.174.10.6416.
J Immunol. 2005.
PMID: 15879143